ArticleJournal of experimental & clinical cancer research : CR2023

Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.

Tianxing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.